Piper Jaffray Cuts Price Target on Endologix (ELGX) to $20 Following 2Q15
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St futures muted as oil tops $100 for first time since July
- Oil nears $100 as fresh Middle East strikes raise supply risks
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
JPMorgan Upgrades Endologix (ELGX) to Overweight
August 6, 2015 6:46 AM EDTJPMorgan upgraded Endologix (NASDAQ: ELGX) from Neutral to Overweight with a price target of $17.00.
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $12.05 yesterday.
... MoreCanaccord Genuity Downgrades Endologix (ELGX) to Hold
August 4, 2015 7:03 AM EDTCanaccord Genuity downgraded Endologix (NASDAQ: ELGX) from Buy to Hold with a price target of $14.00 (from $18.50).
For an analyst ratings summary and ratings history on Endologix click here. For more ratings news on Endologix click here.
Shares of Endologix closed at $14.06 yesterday.
... MoreEndologix (ELGX) Misses Q2 EPS by 5c
August 3, 2015 4:08 PM EDTEndologix (NASDAQ: ELGX) reported Q2 EPS of ($0.18), $0.05 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $39.5 million versus the consensus estimate of $39.35 million.
For earnings history and earnings-related data on Endologix (ELGX) click here.
... MoreTrading Radar for 7/31: Loews (L), Clorox (CLX), Tenet Healthcare (THC), Broadsoft (BSFT) Report
July 31, 2015 3:34 PM EDTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Economics:
8:30am EDT
Earnings:
ArcBest (Nasdaq: ARCB) - consensus EPS $0.76
Array Biopharma (Nasdaq: ARRY) - consensus loss $0.16
Boardwalk Pipeline Partners (NYSE: BWP) - no Street consensus
Broadsoft (Nasdaq:... More
